Apogee Therapeutics (APGE) announced updated positive results from its ongoing Phase 1 clinical trial of APG777, a novel half-life extended ...

The latest update is out from Apogee Therapeutics, Inc. ( (APGE) ).

Here's the inside story of how a former Microsoft staffer turned the best-selling video game Half-Life into a nearly $10 ...